Bohai Pharmaceuticals Group Inc (BOPH) financial statements (2020 and earlier)

Company profile

Business Address C/O YANTAI BOHAI PHARMACEUTICALS GROUP
YANTAI, SHANDONG PROVINCE, 264000
State of Incorp. NV
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments237
Cash and cash equivalents237
Restricted cash and investments13 
Receivables 39
Inventory, net of allowances, customer advances and progress billings53
Inventory53
Other undisclosed current assets4213
Total current assets:8362
Noncurrent Assets
Inventory, Noncurrent5 
Property, plant and equipment2118
Intangible assets, net (including goodwill)8157
Goodwill55
Intangible assets, net (excluding goodwill)7652
Deferred tax assets, net8 
Other undisclosed noncurrent assets(12)29
Total noncurrent assets:102104
TOTAL ASSETS:185166
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2219
Accounts payable 5
Accrued liabilities1612
Employee-related liabilities0 
Taxes payable32
Interest and dividends payable2 
Debt58
Other undisclosed current liabilities1316
Total current liabilities:4044
Noncurrent Liabilities
Liabilities, other than long-term debt 8
Deferred tax liabilities, net 8
Other undisclosed noncurrent liabilities165
Total noncurrent liabilities:1613
Total liabilities:5557
Stockholders' equity
Stockholders' equity attributable to parent130108
Common stock00
Additional paid in capital2525
Accumulated other comprehensive income89
Retained earnings9775
Total stockholders' equity:130108
TOTAL LIABILITIES AND EQUITY:185166

Income statement (P&L) ($ in millions)

6/30/2014
6/30/2013
Revenues175152
Revenue, net 152
Cost of revenue(42)(38)
Cost of goods and services sold (38)
Other undisclosed gross profit 1
Gross profit:133115
Operating expenses(100)(88)
Operating income:3227
Nonoperating income (expense)1(1)
Investment income, nonoperating00
Foreign currency transaction loss, before tax(1) 
Other nonoperating income (expense)1(0)
Interest and debt expense2(2)
Income from continuing operations before equity method investments, income taxes:3524
Other undisclosed income (loss) from continuing operations before income taxes(4)2
Income from continuing operations before income taxes:3226
Income tax expense (benefit)10(7)
Net income:4119
Other undisclosed net loss attributable to parent(19) 
Net income available to common stockholders, basic:2219
Other undisclosed net income available to common stockholders, diluted11
Net income available to common stockholders, diluted:2220

Comprehensive Income ($ in millions)

6/30/2014
6/30/2013
Net income:4119
Comprehensive income:4119
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(20)3
Comprehensive income, net of tax, attributable to parent:2122

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: